Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gem Kramer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Magnetic Resonance Imaging|September 5, 2017
MRI protocol optimization for quantitative DCE-MRI of the spineCristina Lavini, Gem Kramer, Indra Pieters-den Bos, et al.
EJNMMI Research|January 7, 2021
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PETElisabeth Pfaehler, Liesbet Mesotten, Gem Kramer, et al.
Peerj|August 22, 2020
The effect of lip closure on palatal growth in patients with unilateral cleftsRobin Bruggink, Frank Baan, Gem Kramer, et al.
Plos One|April 1, 2020
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variabilityElisabeth Pfaehler, Coreline Burggraaff, Gem Kramer, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 2, 2017
Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's diseaseJeroen J N van Schie, Cristina Lavini, Lucas J van Vliet, et al.
BJR Open|November 12, 2020
Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapyDominic Carlin, Alexander Weller, Gem Kramer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2015
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate CancerDaniela E Oprea-Lager, Gem Kramer, Peter M van de Ven, et al.
The Lancet. Oncology|October 11, 2018
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging GroupFrédéric E Lecouvet, Daniela E Oprea-Lager, Yan Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Magnetic Resonance Imaging|September 5, 2017
MRI protocol optimization for quantitative DCE-MRI of the spineCristina Lavini, Gem Kramer, Indra Pieters-den Bos, et al.
EJNMMI Research|January 7, 2021
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PETElisabeth Pfaehler, Liesbet Mesotten, Gem Kramer, et al.
Peerj|August 22, 2020
The effect of lip closure on palatal growth in patients with unilateral cleftsRobin Bruggink, Frank Baan, Gem Kramer, et al.
Plos One|April 1, 2020
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variabilityElisabeth Pfaehler, Coreline Burggraaff, Gem Kramer, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 2, 2017
Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's diseaseJeroen J N van Schie, Cristina Lavini, Lucas J van Vliet, et al.
BJR Open|November 12, 2020
Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapyDominic Carlin, Alexander Weller, Gem Kramer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2015
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate CancerDaniela E Oprea-Lager, Gem Kramer, Peter M van de Ven, et al.
The Lancet. Oncology|October 11, 2018
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging GroupFrédéric E Lecouvet, Daniela E Oprea-Lager, Yan Liu, et al.
Pageof 1